TRDA Disposition Disclosure
Sethuraman Natarajan · SEC Form 4 · Filed Sep 3, 2026
Disposition
Calculated transaction value
$14.85K
Sethuraman Natarajan President, Research & Develop.
TRDA
Entrada Therapeutics
TRDA
Transaction date
Sep 2, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed 1 day later
TRDA daily price context
Close on/before transaction
$7.3
Sep 2, 2026
Close before public filing
$7.3
Sep 2, 2026
Return since public filing
-6.85%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,079 shares @ $7.14
- SEC ownership
- Direct
- Transaction code
- F
- Form
- 4
- Filing identifier
- 0001873394-26-000005
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$14.85K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Entrada Therapeutics, Inc. TRDA Current | Disposition | Sep 2, 2026 | $14.85K |